Plasmin-mediated fibrinolysis is required for hematopoietic recovery after 5-FU-induced myeloablation
Open Access
- 18 June 2026
- journal article
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (18) , 6079-6089
Abstract
Hematopoietic recovery following myeloablation plays a critical role in the survival of the patients that receive chemotherapy or hematopoietic stem cell transplantation. Understanding the mechanisms underlying hematopoiesis helps identify molecular and/or cellular determinants that could be targeted to enhance hematopoietic recovery. Although several mechanisms by which the plasminogen activation system promotes hematopoietic recovery after myelosuppression have been reported, the specific role fibrinolysis plays in hematopoietic recovery is unclear. The current study employs 5-Fluorouracil-mediated myeloablation in murine models and provides a clear demonstration of uniform extravascular fibrin deposits in the bone marrow niche upon myeloablation. Persistent fibrin deposits in plasminogen-deficient mice lead to failure of hematopoietic recovery. Genetic and pharmacological depletion of fibrinogen following myeloablation restored hematopoietic recovery, revealing the critical role of fibrin in this process. Moreover, defective fibrinolysis led to delayed hematopoietic recovery via a mechanism that involves fibrin engagement with the major myeloid integrin aMb2. Importantly, similar fibrin-rich marrow niches were also observed in human bone marrow injury and failure states. The study identifies a novel molecular pathway that could be therapeutically targeted to enhance hematopoietic recovery following myeloablation.Keywords
This publication has 23 references indexed in Scilit:
- Fibrin drives thromboinflammation and neuropathology in COVID-19Nature, 2024
- Plasminogen activator inhibitor type-1 is a negative regulator of hematopoietic regeneration in the adipocyte-rich bone marrow microenvironmentBiochemical and Biophysical Research Communications, 2021
- Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer’s Disease ModelNeuron, 2019
- Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegenerationNature Immunology, 2018
- Fibrinolysis as a Target to Enhance Fracture HealingNew England Journal of Medicine, 2015
- Inhibition of Plasminogen Activator Inhibitor Type-1 Activity Enhances Rapid and Sustainable Hematopoietic RegenerationStem Cells, 2013
- The Plasminogen Fibrinolytic Pathway Is Required for Hematopoietic RegenerationCell Stem Cell, 2007
- Fibrinogen and Fibrin2005
- Molecular and cellular modulation of fibrinolysisThrombosis and Haemostasis, 2003
- Loss of Fibrinogen Rescues Mice from the Pleiotropic Effects of Plasminogen DeficiencyCell, 1996